Contact Tracing Assessment of COVID-19 Transmission Dynamics in Taiwan and Risk at Different Exposure Periods Before and After Symptom Onset
暂无分享,去创建一个
[1] Lei Liu,et al. Community Transmission of Severe Acute Respiratory Syndrome Coronavirus 2, Shenzhen, China, 2020 , 2020, Emerging infectious diseases.
[2] P. Vollmar,et al. Virological assessment of hospitalized patients with COVID-2019 , 2020, Nature.
[3] Hao-Yuan Cheng,et al. Initial rapid and proactive response for the COVID-19 outbreak — Taiwan's experience , 2020, Journal of the Formosan Medical Association.
[4] Oon Tek Ng,et al. Air, Surface Environmental, and Personal Protective Equipment Contamination by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) From a Symptomatic Patient. , 2020, JAMA.
[5] N. Linton,et al. Serial interval of novel coronavirus (COVID-19) infections , 2020, International Journal of Infectious Diseases.
[6] R. Brook,et al. Response to COVID-19 in Taiwan: Big Data Analytics, New Technology, and Proactive Testing. , 2020, JAMA.
[7] H. Nishiura. Backcalculating the Incidence of Infection with COVID-19 on the Diamond Princess , 2020, Journal of clinical medicine.
[8] P. Klepac,et al. Feasibility of controlling COVID-19 outbreaks by isolation of cases and contacts , 2020, The Lancet Global Health.
[9] Shao-Chung Cheng,et al. First case of Coronavirus Disease 2019 (COVID-19) pneumonia in Taiwan , 2020, Journal of the Formosan Medical Association.
[10] Yunpeng Ji,et al. Potential association between COVID-19 mortality and health-care resource availability , 2020, The Lancet Global Health.
[11] L. Rotz,et al. Initial public health response and interim clinical guidance for the 2019 novel coronavirus outbreak — United States, December 31, 2019–February 4, 2020 , 2020, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[12] Quanyi Wang,et al. Viral load of SARS-CoV-2 in clinical samples , 2020, The Lancet Infectious Diseases.
[13] Zunyou Wu,et al. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. , 2020, JAMA.
[14] C. Viboud,et al. Early epidemiological analysis of the coronavirus disease 2019 outbreak based on crowdsourced data: a population-level observational study , 2020, The Lancet Digital Health.
[15] Min Kang,et al. SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients , 2020, The New England journal of medicine.
[16] M. Lipsitch,et al. Defining the Epidemiology of Covid-19 - Studies Needed. , 2020, The New England journal of medicine.
[17] Yan Zhao,et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. , 2020, JAMA.
[18] Michael Bell,et al. Initial Public Health Response and Interim Clinical Guidance for the 2019 Novel Coronavirus Outbreak — United States, December 31, 2019–February 4, 2020 , 2020, MMWR. Morbidity and mortality weekly report.
[19] Don Klinkenberg,et al. Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travellers from Wuhan, China, 20–28 January 2020 , 2020, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[20] Jing Zhao,et al. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia , 2020, The New England journal of medicine.
[21] G. Gao,et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019 , 2020, The New England journal of medicine.
[22] Y. Hu,et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China , 2020, The Lancet.
[23] Victor M Corman,et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR , 2020, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[24] World Health Organization,et al. Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected. Interim guidance , 2020, Pediatria i Medycyna Rodzinna.
[25] JianShu-Wan,et al. Real-Time Surveillance of Infectious Diseases: Taiwan's Experience. , 2017 .
[26] S. Jian,et al. Real-Time Surveillance of Infectious Diseases: Taiwan's Experience , 2017, Health security.
[27] Jiqiang Guo,et al. Stan: A Probabilistic Programming Language. , 2017, Journal of statistical software.
[28] Ji Hoon Park,et al. Extensive Viable Middle East Respiratory Syndrome (MERS) Coronavirus Contamination in Air and Surrounding Environment in MERS Isolation Wards , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[29] Su-Jin Park,et al. Environmental Contamination and Viral Shedding in MERS Patients During MERS-CoV Outbreak in South Korea , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[30] S. Pocock,et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. , 2007, Preventive medicine.
[31] Matthias Egger,et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies , 2007, PLoS medicine.
[32] J. Robins,et al. Transmission Dynamics and Control of Severe Acute Respiratory Syndrome , 2003, Science.